Harvard University
246
17
32
170
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
6.9%
17 terminated/withdrawn out of 246 trials
90.9%
+4.4% vs industry average
5%
12 trials in Phase 3/4
28%
48 of 170 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (246)
Cool Prime Comparative Effectiveness Study for Mild HIE
Role: collaborator
Liquid Biopsy in Ewing Sarcoma and Osteosarcoma as a Prognostic And Response Diagnostic: LEOPARD
Role: collaborator
Recruiting Healthcare Workers on the International Labor Market: A Megastudy
Role: collaborator
Theophylline Treatment for Pseudohypoparathyroidism
Role: collaborator
Evaluation of a Group-based, Skills Training for Increasing Mental Toughness
Role: collaborator
Leucovorin for the Treatment of Language Impairment in Children With Autism Spectrum Disorder
Role: collaborator
Antibiotic Prophylaxis in Rhinoplasty
Role: collaborator
Impacts of Clinician-Mediated Report-Back
Role: collaborator
Mindful Attention to Variability in Everyday Memory
Role: lead
Attention to Variability During Infertility
Role: lead
A Mindful Community for People With ALS and Their Primary Caregivers
Role: lead
Mindfully Attending to Pain Sensations
Role: lead
Testing FIRST in Youth Outpatient Psychotherapy
Role: lead
Effectiveness of a Smoking Cessation Algorithm Integrated Into HIV Primary Care
Role: collaborator
Kidney Precision Medicine Project
Role: collaborator
Digital CBT for Insomnia and Depression
Role: collaborator
Novel Approaches for Minimizing Drug-Induced QT Interval Lengthening
Role: collaborator
Early Institutionalization Intervention Impact Project
Role: collaborator
Bioboosti Device for Insomnia Treatment
Role: collaborator
Robotic Exosuit Augmented Locomotion (REAL)
Role: collaborator